Spotlight on Clinical Trials
More than 240 clinical trials were presented at the AACR Annual Meeting 2024. The titles and text of the clinical trial abstracts are available on the online itinerary planner. Detailed summaries of these sessions can be found in AACR Annual Meeting News.
Clinical Trial Abstract Sessions
- Clinical Trial Abstract Plenary Sessions
- Clinical Trial Abstract Minisymposia
- Clinical Trial Abstract Poster Sessions
Four experts discussed emerging results from clinical trials evaluating novel immunotherapies.
Four promising studies showcased novel combination therapies for gastroesophageal, colorectal, endometrial, and head and neck cancers.
Experts presented new data on the efficacy and safety of PARP inhibitors and other targeted cancer treatments.
Four trials evaluated biomarkers of efficacy for emerging combination therapies.
The AACR blog reported on two Phase I trials of cancer vaccines presented at the AACR Annual Meeting 2024.
ONLINE PUBLICATION OF ABSTRACTS
The full text of the Clinical Trial and Late-Breaking Abstracts were posted to the AACR Online Itinerary Planner and the Meeting App on April 5, 2024, except those abstracts that were selected for inclusion in the official AACR press program. Abstracts featured in the official AACR press program were made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.
In previous years, abstracts accepted for presentation at the AACR Annual Meeting were published in an online-only Proceedings supplement to the AACR journal Cancer Research after the conclusion of the meeting. For the AACR Annual Meeting 2024, the Proceedings supplement was published prior to the meeting in two parts. Part 1 of the online Proceedings (regular abstracts) was published on March 22, and Part 2 (clinical trials and late-breaking abstracts) was published on April 5.
AACR 2024 Proceedings, Part 1: Regular Abstracts AACR 2024 Proceedings, Part 2: Late-Breaking and Clinical Trial Abstracts